Detailed Information on Publication Record
2015
Role for the microtubule-associated protein tau variant p.A152T in risk of alpha-synucleinopathies
LABBÉ, Catherine, Kotaro OGAKI, Oswaldo LORENZO-BETANCOR, Alexandra I. SOTO-ORTOLAZA, Ronald L. WALTON et. al.Basic information
Original name
Role for the microtubule-associated protein tau variant p.A152T in risk of alpha-synucleinopathies
Authors
LABBÉ, Catherine (840 United States of America), Kotaro OGAKI (840 United States of America), Oswaldo LORENZO-BETANCOR (840 United States of America), Alexandra I. SOTO-ORTOLAZA (840 United States of America), Ronald L. WALTON (840 United States of America), Sruti RAYAPROLU (840 United States of America), Shinsuke FUJIOKA (840 United States of America), Melissa E. MURRAY (840 United States of America), Michael G. HECKMAN (840 United States of America), Andreas PUSCHMANN (752 Sweden), Allan MCCARTHY (372 Ireland), Timothy LYNCH (372 Ireland), Joanna SIUDA (616 Poland), Grzegorz OPALA (616 Poland), Monika RUDZINSKA (616 Poland), Anna KRYGOWSKA-WAJS (616 Poland), Maria BARCIKOWSKA (616 Poland), Krzysztof CZYZEWSKI (616 Poland), Yanosh SANOTSKY (804 Ukraine), Irena REKTOROVÁ (203 Czech Republic, guarantor, belonging to the institution), Pamela J. MCLEAN (840 United States of America), Rosa RADEMAKERS (840 United States of America), Niluefer ERTEKIN-TANER (840 United States of America), Anhar HASSAN (840 United States of America), J. Eric AHLSKOG (840 United States of America), Bradley F. BOEVE (840 United States of America), Ronald C. PETERSEN (840 United States of America), Demetrius M. MARAGANORE (840 United States of America), Charles H. ADLER (840 United States of America), Tanis J. FERMAN (840 United States of America), Joseph E. PARISI (840 United States of America), Neill R. GRAFF-RADFORD (840 United States of America), Ryan J. UITTI (840 United States of America), Zbigniew K. WSZOLEK (840 United States of America), Dennis W. DICKSON (840 United States of America) and Owen A. ROSS (840 United States of America)
Edition
Neurology, Philadelphia, LIPPINCOTT WILLIAMS & WILKINS, 2015, 0028-3878
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
30000 3. Medical and Health Sciences
Country of publisher
United States of America
Confidentiality degree
není předmětem státního či obchodního tajemství
References:
Impact factor
Impact factor: 8.166
RIV identification code
RIV/00216224:14740/15:00085057
Organization unit
Central European Institute of Technology
UT WoS
000364338500009
Keywords in English
adult; aged; alpha synucleinopathies; Article; case control study; controlled study; degenerative disease; diffuse Lewy body disease; disease predisposition
Tags
International impact, Reviewed
Změněno: 4/4/2016 15:00, Mgr. Eva Špillingová
Abstract
V originále
Objective: To assess the importance of MAPT variant p.A152T in the risk of synucleinopathies. Methods: In this case-control study, we screened a large global series of patients and controls, and assessed associations between p.A152T and disease risk. We included 3,229 patients with clinical Parkinson disease (PD), 442 with clinical dementia with Lewy bodies (DLB), 181 with multiple system atrophy (MSA), 832 with pathologically confirmed Lewy body disease (LBD), and 2,456 healthy controls. Results: The minor allele frequencies (MAF) in clinical PD cases (0.28%) and in controls (0.2%) were not found to be significantly different (odds ratio [OR] 1.37, 95% confidence interval [CI] 0.63-2.98, p 0.42). However, a significant association was observed with clinical DLB (MAF 0.68%, OR 5.76, 95% CI 1.62-20.51, p 0.007) and LBD (MAF 0.42%, OR 3.55, 95% CI 1.04-12.17, p 0.04). Additionally, p.A152T was more common in patients with MSA compared to controls (MAF 0.55%, OR 4.68, 95% CI 0.85-25.72, p 0.08) but this was not statistically significant and therefore should be interpreted with caution. Conclusions: Overall, our findings suggest that MAPT p.A152T is a rare low penetrance variant likely associated with DLB that may be influenced by coexisting LBD and AD pathology. Given the rare nature of the variant, further studies with greater sample size are warranted and will help to fully explain the role of p.A152T in the pathogenesis of the synucleinopathies. © 2015 American Academy of Neurology.